Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synbiotic Therapy in CKD Stage III-IV
NCT07912359Recruiting
- Sponsor
- Chattogram Medical College
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic kidney disease (CKD) (2 arms), sponsored by Chattogram Medical College. Primary endpoints: Change in Serum Creatinine at 3 months, Change in Estimated Glomerular Filtration Rate at 3 months and 1 more. Started Oct 2026; status: recruiting.
02
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07912359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07912359.